Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
20. Februar 2024 07:45 ET
|
Gracell Biotechnologies Inc.
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical...
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK
11. Februar 2021 04:00 ET
|
Rentschler Biopharma SE; The Cell and Gene Therapy Catapult
Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...